| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/16/2006 | CA2512060A1 Transdermal drug delivery formulations and method of determining optimal amounts of vasodilators therein |
| 01/15/2006 | CA2471884A1 High oleic acid brassica juncea |
| 01/13/2006 | CA2473814A1 Method and markers for the diagnosis of renal diseases |
| 01/12/2006 | WO2006005065A2 Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detection |
| 01/12/2006 | WO2006005054A2 System and methods for the management and treatment of vascular graft disease |
| 01/12/2006 | WO2006005024A1 Molecular property modeling using ranking |
| 01/12/2006 | WO2006004986A1 Estimating the accuracy of molecular property models and predictions |
| 01/12/2006 | WO2006004958A2 Detection or measurement of antibodies to antigenic proteins in biological tissues or samples |
| 01/12/2006 | WO2006004936A2 Analysis of intracellular modifications |
| 01/12/2006 | WO2006004739A2 Method of pre-treatment and staining of and support device for a biological sample |
| 01/12/2006 | WO2006004635A1 Method and apparatus for meat scanning |
| 01/12/2006 | WO2006004627A1 An apparatus and method for delivering a test strip to a meter test port in a predetermined orientation |
| 01/12/2006 | WO2006004598A2 Proteomic analysis |
| 01/12/2006 | WO2006004569A2 Algorithm for estimation of multiple faults on a transmission line or waveguide |
| 01/12/2006 | WO2006004405A1 Method for predicting final saturation of an organic liquid phase in a porous medium |
| 01/12/2006 | WO2006004394A2 Method for detecting gluten |
| 01/12/2006 | WO2006004194A1 METHOD OF SCREENING REMEDY FOR ALZHEIMER’S DISEASE TARGETING TGF β2 |
| 01/12/2006 | WO2006004039A1 Immunoassay apparatus and method |
| 01/12/2006 | WO2006003657A2 Indicator strip and a device for automatic testing of liquids |
| 01/12/2006 | WO2006003518A2 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 01/12/2006 | WO2006003472A1 Delta-9-tetrahydrocannabinol detection method |
| 01/12/2006 | WO2006003427A1 A protein involved in carcinoma |
| 01/12/2006 | WO2006003423A2 Gel formulations and uses thereof |
| 01/12/2006 | WO2006003422A1 Use of the receptor gpr86 |
| 01/12/2006 | WO2006003414A2 Biomarkers of alzheimer's disease |
| 01/12/2006 | WO2006003397A2 Membrane fusion assay |
| 01/12/2006 | WO2006003394A1 Analyte detection system |
| 01/12/2006 | WO2006003330A2 Collections of traceable compounds and uses thereof |
| 01/12/2006 | WO2006003329A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | WO2006003209A1 Use of uteroglobin as a marker for human oncological and infectious diseases |
| 01/12/2006 | WO2006003100A1 Functional screening assay |
| 01/12/2006 | WO2006003029A2 Detection of tuberculosis and infection by mycobacterium tuberculosis using hbha |
| 01/12/2006 | WO2006003022A2 Method for evaluating biochips |
| 01/12/2006 | WO2006002930A2 FcϜRIIa POLYMORPHISM AND ITS USE IN DIAGNOSIS |
| 01/12/2006 | WO2006002888A1 Gas-monitoring assembly comprising one or more gas sensors and one or more getters, and method of using same |
| 01/12/2006 | WO2006002841A2 Analysis method |
| 01/12/2006 | WO2006002616A1 Composite materials comprising tetraether lipids and production of said materials |
| 01/12/2006 | WO2006002608A1 Method for determining the authenticity of materials by means of substances which are isotopically marked with oxygen 18 |
| 01/12/2006 | WO2005119252A3 Modulators of gpr35 for the treatment of metabolic-related disorders |
| 01/12/2006 | WO2005111624A3 Mhc bridging system for detecting ctl-mediated lysis of antigen presenting cells |
| 01/12/2006 | WO2005111608A3 Transmissible spongiform encephalopathy test reagents and methods using them |
| 01/12/2006 | WO2005106760A3 Chemical and biological agent sensor array |
| 01/12/2006 | WO2005106475A3 Novel method for determination of plasminogen activator inhibitor |
| 01/12/2006 | WO2005106462A3 Methods for use of fluorescent nanoparticles to determine free volume and to detect and deliver materials to repair cracks in polymers and polymer composites |
| 01/12/2006 | WO2005103693A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 01/12/2006 | WO2005103295A3 Method and tools for analysis of nucleic acids |
| 01/12/2006 | WO2005101014A3 Diagnostic and therapeutic use of kcnc1 for neurodegenerative diseases |
| 01/12/2006 | WO2005100603A3 Tape stripping methods for analysis of skin disease and pathological skin state |
| 01/12/2006 | WO2005094810A3 Novel pharmaceutical compositions |
| 01/12/2006 | WO2005094382A3 A flow cytometric method and kit for metal-induced sensitivity |
| 01/12/2006 | WO2005090606A3 Identification of toxic nucleotide sequences |
| 01/12/2006 | WO2005090573A3 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/12/2006 | WO2005070448A3 Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease |
| 01/12/2006 | WO2005059551A3 Method and system for the analysis of saliva using a sensor array |
| 01/12/2006 | WO2005054865A3 Diagnostics and therapeutics for diseases associated with protein-coupled inwardly rectifying potassium channel (girk1) |
| 01/12/2006 | WO2005046619A3 Compositions and methods for modulating c-rel-dependent cytokine production |
| 01/12/2006 | WO2005046449A3 Soluble tcr molecules and methods of use |
| 01/12/2006 | WO2005041746A3 Optical sensor and methods for measuring molecular binding interactions |
| 01/12/2006 | WO2005033693A3 Method and apparatus for determining a total concentration of a component in a mixure of components |
| 01/12/2006 | WO2005033266A3 Regulation of acheron expression |
| 01/12/2006 | WO2005016287A3 Prkwnks as modifiers of the rac pathway and methods of use |
| 01/12/2006 | WO2005009203A3 Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis |
| 01/12/2006 | WO2005003303A3 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/12/2006 | WO2004106495A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 01/12/2006 | WO2004099774A3 Processes for the identification of medical targets by screening an active agent for binding interactions |
| 01/12/2006 | WO2004099767A3 Biomolecular switching device using a holliday junction dna |
| 01/12/2006 | WO2004085539A3 Cyanine dye labelling reagents with meso-substitution |
| 01/12/2006 | WO2004078130A3 Posh interacting proteins and related methods |
| 01/12/2006 | WO2004067720A3 Systems and methods for predicting specific genetic loci that affect phenotypic traits |
| 01/12/2006 | WO2004032851A3 Screening and therapeutic methods relating to neurogenesis |
| 01/12/2006 | WO2004031354A3 Human sarcoma-associated antigens |
| 01/12/2006 | WO2003087758A3 Peptides for detection of antibody to a. phagocytophila |
| 01/12/2006 | US20060010195 Service oriented architecture for a message broker in a data integration platform |
| 01/12/2006 | US20060010014 Remote health monitoring and maintenance system |
| 01/12/2006 | US20060009922 Method for interpreting tandem mass spectrometry data for clinical diagnosis of genetic disorders such as citrullinemia |
| 01/12/2006 | US20060009917 Feature extraction methods and systems |
| 01/12/2006 | US20060009915 Rapid and quantitative proteome analysis and related methods |
| 01/12/2006 | US20060009914 Detection and identification of nucleic acid, peptide, and protein modifications |
| 01/12/2006 | US20060009913 System and methods for predicting transmembrane domains in membrane proteins and mining the genome for recognizing G-protein coupled receptors |
| 01/12/2006 | US20060009912 Microbiological information system |
| 01/12/2006 | US20060009879 Programming and diagnostic tool for a mobile robot |
| 01/12/2006 | US20060009706 System and method for monitoring air flow from a person |
| 01/12/2006 | US20060009705 System and method for monitoring air flow from a person |
| 01/12/2006 | US20060009632 Nucleotide sequences coding metalloenzymes and/or aggrecanase for use in identifying modulators for prevention and treatment of bone disorders |
| 01/12/2006 | US20060009631 Nucleic acids encoding this enzyme; in humans, rodents; isotopes; purity; gene expression; transformation, translation of cells; sulfation of tyrosine; hybridization |
| 01/12/2006 | US20060009630 Composition for treating squamous cell carcinoma comprising an antibody that specifically binds a migration facilitating protein comprising a laminin 5 alpha 3 G4 and/or 5 domain or subdomain thereof, and a pharmaceutically acceptable carrier; treatment of skin cancer |
| 01/12/2006 | US20060009623 C-terminal attachment of ligands to proteins for immobilization onto a support |
| 01/12/2006 | US20060009621 For detecting a PMS2 protein, including a truncated PMS2, for detecting a predisposition to cancer, monoclonal antibody |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009470 Method for specifically potentiating N-type Ca2+ channel activity |
| 01/12/2006 | US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics |
| 01/12/2006 | US20060009257 Multifunctional personal portable digital image capturing device |
| 01/12/2006 | US20060008924 Modulated physical and chemical sensors |
| 01/12/2006 | US20060008923 Point of care diagnostic systems |
| 01/12/2006 | US20060008922 An internal standard preparation containing 2H9-carnitine, 2H3-acetylcarnitine, 2H3-propionylcarnitine, 2H3-butyrylcarnitine, 2H9-isovalerylcarnitine, 2H3-octanoylcarnitine, 2H9-myristoylcarnitine, and 2H3-palmitoylcarnitine. |
| 01/12/2006 | US20060008921 Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels |
| 01/12/2006 | US20060008920 Combination assay for alcohol and drugs of abuse |
| 01/12/2006 | US20060008918 Non-invasive diagnosis by analysis (mass spectroscopy, gas chromatography or electronic nose) of flatus or gas evolved from stool; presence or absence of a predetermined volatile compound is indicative of a disease state; diarrhea |
| 01/12/2006 | US20060008917 Diagnostic methods for determining susceptibility to convulsive conditions |